✦ LIBER ✦

mTOR signaling is a promising therapeutic target in a subset of human pancreatic ductal adenocarcinomas

✍ Scribed by Morran, D.C.; Karim, S.A.; Jamieson, N.B.; McKay, C.J.; Carter, R.; Evans, T.R.J.; Sansom, O.J.; Morton, J.P.

Book ID: 122385162
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 43 KB
Volume: 13
Category: Article
ISSN: 1424-3903
DOI: 10.1016/j.pan.2012.12.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amplification and overexpression of the

Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas

✍ Bruce A. Ruggeri; Lingyi Huang; Moira Wood; Jin Quan Cheng; Joseph R. Testa 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

AKT2, an oncogene encoding a protein serine-threonine kinase implicated in phosphatidylinositol-3-OH kinase signaling, is amplified in some human ovarian and pancreatic carcinomas. We previously demonstrated that the tumorigenicity and invasiveness of pancreatic ductal adenocarcinoma (PDAC) cell lin

301 Genomic discovery, characterization

301 Genomic discovery, characterization and validation of a transmembrane protein overexpressed in human ovarian and pancreatic cancers: a promising new target for therapeutic monoclonal antibodies

✍ J. Papkoff; W. Liu; T. Tang; A. Munteanu; S. Zhuo; Y. Liu; S. Salceda; R. Macina 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

204 POSTER Discovery and validation of a

204 POSTER Discovery and validation of a promising new target for therapeutic monoclonal antibodies: a type II transmembrane serine protease overexpressed in human ovarian and pancreatic cancers

✍ J. Papkoff; A. Strelow; S. Lee; A. Nguyen; G. Diedrich; S. Zhuo; W. Liu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB